Ann Intern Med

1. TAKANASHI S, Ohmura K, Sumitomo S, Oka H, et al
   Timing of Recombinant Herpes Zoster Virus Vaccination Administration and JAK Inhibitor Initiation in Rheumatoid Arthritis: A Multicenter, Open-Label, Randomized Comparative Study.
   Ann Intern Med. 2026 Jul 21. doi: 10.7326/ANNALS-25-05493.
   

   >> Share

   
   

   
   Arch Virol

2. ENKHMANDAKH Y, Odonchimeg M, Munkhtsetseg A, Batmagnai E, et al
   Effective inactivated lumpy skin disease vaccine for cattle using a field viral strain and Montanide 206.
   Arch Virol. 2026;171:234.
   

   >> Share

   
   

   
   BMJ

3. O'DOWD A
   Covid vaccine: NHS eligibility should rise to 80 next year, say expert advisers.
   BMJ. 2026;394:e100368.
   

   >> Share

   
   

   
   Clin Infect Dis

4. CHEN WH, Haidara FC, Diallo F, Tapia MD, et al
   Persistence of Serum Bactericidal Antibody in the First 2-Years After Immunization with Pentavalent Meningococcal ACWYX Vaccine in Malian Infants and Toddlers.
   Clin Infect Dis. 2026 Jul 22:ciag449. doi: 10.1093.
   

   >> Share

   
   

   
   J Infect

5. QUINOT C, Lunt R, Kirsebom F, Andrews N, et al
   Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England.
   J Infect. 2026;93:106819.
   

   >> Share

   
   

   
   J Infect Dis

6. ZHOU W
   Repeated Influenza Vaccination in Children: Effect Scale, Timing, and Causal Interpretation.
   J Infect Dis. 2026 Jul 24:jiag386. doi: 10.1093.
   

   >> Share

   
   
7. TALBOT HK
   Vaccines in the Golden Years.
   J Infect Dis. 2026 Jul 23:jiag382. doi: 10.1093.
   

   >> Share

   
   
8. SIMOES EAF, Madhi SA, Center KJ, Tita ATN, et al
   Phase 2 Randomized Bivalent RSVpreF Maternal Vaccine Trial: Final Safety, Antibody Persistence and Efficacy.
   J Infect Dis. 2026 Jul 23:jiag378. doi: 10.1093.
   

   >> Share

   
   
9. ZEREBINSKI J, Broumou I, Kimenyi KM, Aklillu E, et al
   Widespread variants of the highly polymorphic Plasmodium falciparum vaccine candidate antigen MSP2 across Sub-Saharan Africa.
   J Infect Dis. 2026 Jul 22:jiag377. doi: 10.1093.
   

   >> Share

   
   

   
   J Virol

10. ERICKSON R, Bates P
    Immunogenicity of recombinant vesicular stomatitis virus-vectored vaccines expressing the Machupo virus glycoprotein in different genome positions.
    J Virol. 2026 Jul 24:e0035726. doi: 10.1128/jvi.00357.
    

    >> Share

    
    
11. BEETON K, Case JB
    Respiratory mucosal vaccines for emerging viruses: promise and challenges.
    J Virol. 2026 Jul 23:e0174825. doi: 10.1128/jvi.01748.
    

    >> Share

    
    
12. TIWAREKAR V, Ebenig A, Predota Y, Schrauf S, et al
    Minor differences in the untranslated regions of measles vector additional transcription units are reflected by differential immunogenicity of encoded MERS-CoV Spike antigen.
    J Virol. 2026 Jul 1:e0064426. doi: 10.1128/jvi.00644.
    

    >> Share

    
    
13. CHATTERJEE A, Mangala Prasad V
    Role of quaternary epitopes in eliciting broad neutralization response against multiple flaviviruses.
    J Virol. 2026;100:e0177725.
    

    >> Share

    
    
14. XU S, Zhang Q, Xie X, Zhou M, et al
    A neutralizing nanobody targeting a conserved lateral patch on HA1 confers protection against multiple H7 avian influenza viruses.
    J Virol. 2026 Jun 11:e0056326. doi: 10.1128/jvi.00563.
    

    >> Share

    
    

    
    JAMA

15. ANDERER S
    Flu Vaccine Remains Highly Effective Against Pediatric Mortality.
    JAMA. 2026 Jul 24. doi: 10.1001/jama.2026.9486.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

16. DAHLKE M, Dautel KA, Vynnycky E, Still C, et al
    Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2024.
    MMWR Morb Mortal Wkly Rep. 2026;75:356-363.
    

    >> Share

    
    

    
    N Engl J Med

17. LHOMME E, Wiedemann A, Ayouba A, Ben-Farhat S, et al
    Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines.
    N Engl J Med. 2026 Jul 22. doi: 10.1056/NEJMc2608018.
    

    >> Share

    
    
18. MONTO AS, Chu HY
    The Best of Both Worlds - Using Clinical Trial and Observational Data to Evaluate Vaccine Protection.
    N Engl J Med. 2026;395:313-316.
    

    >> Share

    
    

    
    Pediatrics

19. KAO CM, Bahakel H, Heald-Sargent TA, Minniear TD, et al
    Influenza, COVID-19, and RSV Vaccinations for Immunocompromised Children and Household Contacts.
    Pediatrics. 2026 Jul 23:e2026075971. doi: 10.1542/peds.2026-075971.
    

    >> Share

    
    

    
    PLoS Comput Biol

20. XU R, Ghaffarzadegan N, Zhang G, Aoki G, et al
    Population-level behavioral and structural drivers of COVID-19 vaccine uptake in the US.
    PLoS Comput Biol. 2026;22:e1013988.
    

    >> Share

    
    

    
    PLoS One

21. CHURCHILL BF, Gao XS, Rong R
    Partisan differences in healthcare decision-making: Evidence from a vaccine experiment.
    PLoS One. 2026;21:e0352319.
    

    >> Share

    
    
22. JANSEN J, Vlaming KE, Helgers LC, Schumacher E, et al
    Adjuvants MPLA and SMNP induce antiviral immunity and indirectly revert HIV-1 latency.
    PLoS One. 2026;21:e0348959.
    

    >> Share

    
    
23. CUI YA, Li Y, Yang L, Cui ZA, et al
    HPV vaccination intention and its association with vaccine hesitancy and health beliefs among unvaccinated Chinese medical college students: A cross-sectional study.
    PLoS One. 2026;21:e0354119.
    

    >> Share

    
    
24. MSUYA HM, Lwambura S, Msuya I, Lweno O, et al
    Spatial distribution and associated factors influencing 2024 Measles-Rubella vaccination campaign coverage among children aged 9-59 months in Mainland Tanzania: A multi-level mixed-effect analysis.
    PLoS One. 2026;21:e0330134.
    

    >> Share

    
    
25. ZENEBE S, Yeheyis T, Tadesse F, Deribe B, et al
    Perceived facilitators and barriers against human papillomavirus vaccine among rural parents with eligible daughters in the Alle district, Southern Ethiopia.
    PLoS One. 2026;21:e0354372.
    

    >> Share

    
    
26. ELLIS K, Hall P, Robinson L, Ruiz S, et al
    COVID-19 vaccine confidence among adults of pima county using the NIMHD minority health and health disparities research framework: A qualitative analysis.
    PLoS One. 2026;21:e0353345.
    

    >> Share

    
    
27. LA EM, Gallington K, Singer D, Fikre T, et al
    US healthcare professionals' knowledge, attitudes, and practices regarding RSV disease and vaccination in adults during the 2024-2025 RSV season.
    PLoS One. 2026;21:e0353266.
    

    >> Share

    
    
28. KENNEDY KL, Queen TL, Ellingson MK, Elias EH, et al
    Parents' role as advocates for and against childhood vaccination: Findings from a nationally representative survey.
    PLoS One. 2026;21:e0354147.
    

    >> Share

    
    
29. ESMAIL NIA G, Shahosseini Z, Akbari E, Bamehr H, et al
    Orientation of Gp96 and Calreticulin T-cell epitopes in a multiepitope HPV16 E7 vaccine construct affects predicted immunostimulatory properties: An in silico and expression validation study.
    PLoS One. 2026;21:e0353860.
    

    >> Share

    
    

    
    Science

30. KUPFERSCHMIDT K
    Ebola's rapid spread spurs new drug and vaccine trials.
    Science. 2026;393:338-339.
    

    >> Share

    
    

    
    Vaccine

31. TRICOU V, Saez-Llorens X, Kosalaraksa P, Reynales H, et al
    Characterization of vaccine viremia, attenuation reversion, and safety: Combined results from the TAK-003 dengue vaccine clinical development program.
    Vaccine. 2026;88:128917.
    

    >> Share

    
    
32. BELL S, Chantler T, Passanante A, Pryce J, et al
    Maternal respiratory syncytial virus (RSV) vaccine perceptions amongst pregnant women and mothers of infants and toddlers in England: a qualitative study.
    Vaccine. 2026;88:128955.
    

    >> Share

    
    
33. SENDEKIE AK, Chalmers L, Sim TF, Czarniak P, et al
    Navigating ethical dilemmas during child and adolescent vaccinations: a scoping review.
    Vaccine. 2026;88:128943.
    

    >> Share

    
    
34. DIARRA M, Li S, Gaur S, Greenberg P, et al
    Understanding parent motivation for participating in the Pfizer COVID-19 vaccine trial.
    Vaccine. 2026;88:128960.
    

    >> Share

    
    
35. WANG WC, Alhashimi M, Gairola V, Murala MST, et al
    Lung-resident T-cell immunity dominates protection induced by an intranasal adenoviral nucleoprotein influenza vaccine.
    Vaccine. 2026;88:128962.
    

    >> Share

    
    
36. LINNEGAR B, McCallum H, Peel AJ
    Longitudinal and spatial declines in equine Hendra virus vaccination despite continued risk.
    Vaccine. 2026;88:128937.
    

    >> Share

    
    
37. CIRUELA P, Broner S, Moraga-Llop F, de Sevilla MF, et al
    Persistent vaccine-type invasive pneumococcal disease in children despite high PCV13 coverage: the role of serotype 3.
    Vaccine. 2026;88:128940.
    

    >> Share

    
    
38. YOON SK, Phillips AL, Battan-Wraith S, Thiese MS, et al
    Real-world effectiveness and safety of protein-based and mRNA COVID-19 vaccines (BEEHIVE trial).
    Vaccine. 2026;88:128954.
    

    >> Share

    
    
39. OKOLI GN, Sullivan SG, Harper DM, Tsang TK, et al
    A systematic meta-analytic comparative evaluation of seasonal influenza vaccine effectiveness from test-negative design studies in the Northern Hemisphere pre/post COVID-19 pandemic.
    Vaccine. 2026;88:128956.
    

    >> Share

    
    
40. DE WEERDT L, Thiriard A, Vu Duc I, Reviya N, et al
    Timing of maternal Tdap vaccination: A dynamic balance between antibody induction and placental transfer efficiency.
    Vaccine. 2026;88:128953.
    

    >> Share

    
    
41. HSU CH, Chen CF, Chu KA, Lin MH, et al
    HPV vaccination and the risk of cancer in males.
    Vaccine. 2026;88:128923.
    

    >> Share

    
    
42. EBRAHIMI N, de Whalley P, Kanji N, Ramasamy MN, et al
    ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.
    Vaccine. 2026;88:128951.
    

    >> Share

    
    
43. LOBO GAITAN FB, Gonzalez-Mora RD, Tutti S, Igarza RC, et al
    Adjuvant properties of baculovirus enhance the immunogenicity and protective efficacy of foot-and-mouth disease virus-like particles vaccines in mice.
    Vaccine. 2026;88:128958.
    

    >> Share

    
    
44. DALEXIS RD, Beogo I, Xu Y, Muray M, et al
    Post-COVID-19 pandemic inequities in routine childhood immunization in Canada: racial disparities in uptake of polio, meningococcal conjugate, and varicella vaccines.
    Vaccine. 2026;88:128931.
    

    >> Share

    
    
45. HUSSAIN HS, Yousafzai MT, Iqbal J, Aslam ZM, et al
    Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: A non-inferiority, randomized, double-blind, phase IV clinical trial in Pakistan.
    Vaccine. 2026;88:128918.
    

    >> Share

    
    
46. MAKRAM AM, Thien DH, Bombana M, Huy NT, et al
    Is it time to investigate the safety of live-attenuated vaccines during pregnancy?
    Vaccine. 2026;88:128959.
    

    >> Share

    
    
47. GOTTARDO R, Dean H, Nascimento EJM, Tricou V, et al
    Beyond neutralization: A comprehensive framework for evaluating humoral immunity induced by a live-attenuated tetravalent dengue vaccine.
    Vaccine. 2026;88:128929.
    

    >> Share

    
    
48. WONG JM, Acevedo PK, Whitehead S, Durbin A, et al
    Dengue vaccines: The role of a correlate of protection in evaluating vaccine safety and risk.
    Vaccine. 2026;88:128599.
    

    >> Share

    
    
49. REAGAN EK, Wright DA, Clark KE, Mercado-Lopez X, et al
    mRNA-LNP hepatitis C vaccine encoding p7 elicits improved humoral immunogenicity.
    Vaccine. 2026;88:128938.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share